P A Pinto

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Commentary on: "Focal cryosurgical ablation of the prostate: A single institute's perspective"
    Adam R Metwalli
    Urologic Oncology Branch, National Cancer Institute, NIH, Building 10, Room 2W 5940, 10 Center Drive, MSC 1210, Bethesda, MD 2089s, USA
    BMC Urol 13:39. 2013
  2. pmc A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report
    Phuong L Mai
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Med Case Reports 1:9. 2007
  3. pmc Non-invasive monitoring of tissue oxygenation during laparoscopic donor nephrectomy
    Nicole J Crane
    Naval Medical Research Center, Combat Casualty Care, Silver Spring, MD 20910, USA
    BMC Surg 8:8. 2008
  4. doi request reprint Renal carcinoma: minimally invasive surgery of the small renal mass
    Peter A Pinto
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Urol Oncol 27:335-6. 2009
  5. pmc Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging
    Peter A Pinto
    Urologic Oncology Branch, Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1210, USA
    J Urol 186:1281-5. 2011
  6. ncbi request reprint Tips and tricks of laparoscopic partial nephrectomy
    B McHone
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Minerva Urol Nefrol 62:273-81. 2010
  7. pmc BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports
    J R Toro
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Executive Plaza South, Room 7012, Rockville, MD 20892 7231, USA
    J Med Genet 45:321-31. 2008
  8. pmc Molecular diagnosis and therapy of kidney cancer
    W Marston Linehan
    Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA
    Annu Rev Med 61:329-43. 2010
  9. pmc Hereditary kidney cancer: unique opportunity for disease-based therapy
    W Marston Linehan
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Building 10 CRC, Room 1 5940, Bethesda, MD 20892 1107, USA
    Cancer 115:2252-61. 2009
  10. ncbi request reprint Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes
    Gennady Bratslavsky
    Urologic Oncology Branch and Molecular Imaging Program PLC, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 1107, USA
    J Urol 179:67-70. 2008

Collaborators

Detail Information

Publications29

  1. pmc Commentary on: "Focal cryosurgical ablation of the prostate: A single institute's perspective"
    Adam R Metwalli
    Urologic Oncology Branch, National Cancer Institute, NIH, Building 10, Room 2W 5940, 10 Center Drive, MSC 1210, Bethesda, MD 2089s, USA
    BMC Urol 13:39. 2013
    ..The developing role of imaging for prostate tumors will dramatically change and likely improve the treatment morbidity for low risk prostate tumors. Commentary on: http://www.biomedcentral.com/1471-2490/13/2. ..
  2. pmc A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report
    Phuong L Mai
    Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Med Case Reports 1:9. 2007
    ..Familial testicular cancer in the presence of other findings in affected and unaffected family members might indicate a previously-unidentified hereditary cancer syndrome...
  3. pmc Non-invasive monitoring of tissue oxygenation during laparoscopic donor nephrectomy
    Nicole J Crane
    Naval Medical Research Center, Combat Casualty Care, Silver Spring, MD 20910, USA
    BMC Surg 8:8. 2008
    ..However, there is no in vivo methodology to monitor renal parenchymal oxygenation during laparoscopic surgery...
  4. doi request reprint Renal carcinoma: minimally invasive surgery of the small renal mass
    Peter A Pinto
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Urol Oncol 27:335-6. 2009
    ..Currently, minimally invasive partial nephrectomy has become an option in the treatment of small renal masses...
  5. pmc Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging
    Peter A Pinto
    Urologic Oncology Branch, Clinical Center and National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1210, USA
    J Urol 186:1281-5. 2011
    ..The cancer detection rates for the first 101 patients are reported...
  6. ncbi request reprint Tips and tricks of laparoscopic partial nephrectomy
    B McHone
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Minerva Urol Nefrol 62:273-81. 2010
    ..The following review is designed to assist the urologic surgeon in performing a successful laparoscopic partial nephrectomy by detailing the "tips and tricks" of the procedure...
  7. pmc BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports
    J R Toro
    Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Executive Plaza South, Room 7012, Rockville, MD 20892 7231, USA
    J Med Genet 45:321-31. 2008
    ..Germline mutations in BHD are associated with the susceptibility for BHDS. We previously described 51 BHDS families with BHD germline mutations...
  8. pmc Molecular diagnosis and therapy of kidney cancer
    W Marston Linehan
    Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA
    Annu Rev Med 61:329-43. 2010
    ..Knowledge of these kidney cancer gene pathways has enabled new approaches in the management of this disease and has provided the foundation for the development of targeted therapeutics...
  9. pmc Hereditary kidney cancer: unique opportunity for disease-based therapy
    W Marston Linehan
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Building 10 CRC, Room 1 5940, Bethesda, MD 20892 1107, USA
    Cancer 115:2252-61. 2009
    ..Studies of the tricarboxylic acid cycle and the VHL-HIF pathways have provided the foundation for therapeutic approaches in patients with HLRCC-associated kidney cancer as well as other hereditary and sporadic forms of RCC...
  10. ncbi request reprint Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes
    Gennady Bratslavsky
    Urologic Oncology Branch and Molecular Imaging Program PLC, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 1107, USA
    J Urol 179:67-70. 2008
    ..We evaluated outcomes in patients who underwent third or fourth partial nephrectomies on the same kidney, which we call salvage partial nephrectomy...
  11. ncbi request reprint Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics
    W Marston Linehan
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    Clin Cancer Res 13:671s-679s. 2007
    ..These Mendelian single-gene syndromes provide a unique opportunity to evaluate the effectiveness of agents that target the VHL, c-Met, BHD, and fumarate hydratase pathways...
  12. pmc Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes
    Nick W Liu
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1414, USA
    J Urol 183:1719-24. 2010
    ..We examined outcomes in patients with recurrent or de novo renal lesions treated with repeat partial nephrectomy on a solitary kidney...
  13. pmc Initial experience with robot assisted partial nephrectomy for multiple renal masses
    Ronald Boris
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 1107, USA
    J Urol 182:1280-6. 2009
    ..We evaluated the feasibility of performing robot assisted partial nephrectomy in patients with multiple renal masses and examined the results of our initial experiences...
  14. pmc The clinical implications of the genetics of renal cell carcinoma
    Inger Rosner
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Urol Oncol 27:131-6. 2009
    ..Advances in molecular therapeutics offer novel treatment options for patients with advanced disease...
  15. ncbi request reprint Genetic basis of kidney cancer: a model for developing molecular-targeted therapies
    Manish A Vira
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 1107, USA
    BJU Int 99:1223-9. 2007
  16. pmc Feasibility and outcomes of repeat partial nephrectomy
    Aaron Johnson
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 1107, USA
    J Urol 180:89-93; discussion 93. 2008
    ..Management options for recurrent tumors include completion nephrectomy, ablation and repeat partial nephrectomy. We examine the feasibility and outcomes of repeat partial nephrectomy performed on the same renal unit...
  17. pmc Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm
    Gopal N Gupta
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Urol 184:59-63. 2010
    ..We present oncological outcomes in patients with hereditary renal cell carcinoma treated with partial nephrectomy for multifocal solid tumors with the largest lesion greater than 4 cm...
  18. pmc Robotic partial nephrectomy for complex renal tumors: surgical technique
    Craig G Rogers
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Eur Urol 53:514-21. 2008
    ..We describe our technique, illustrated with video, of robotic partial nephrectomy for complex renal tumors, including hilar, endophytic, and multiple tumors...
  19. ncbi request reprint Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer
    Robert L Grubb
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Urol 177:2074-9; discussion 2079-80. 2007
    ..We report the clinical characteristics and urological treatment of patients with hereditary leiomyomatosis and renal cell cancer associated renal tumors...
  20. ncbi request reprint Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer
    Sunil Sudarshan
    Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 1107, USA
    Nat Clin Pract Urol 4:104-10. 2007
    ..Nevertheless, continued investigation of HLRCC should provide further insight into the mechanisms of kidney cancer development, and could potentially identify targets for new therapeutic approaches to RCC...
  21. ncbi request reprint Management of von Hippel-Lindau-associated kidney cancer
    Robert L Grubb
    Urologic Oncology at the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    Nat Clin Pract Urol 2:248-55. 2005
    ..Elucidation of molecular pathways associated with VHL renal tumors may facilitate development of effective medical treatments for these lesions in the future...
  22. pmc Layered peptide array for multiplex immunohistochemistry
    Gallya Gannot
    Pathogenetics Unit, Advanced Technology Center, Laboratory of Pathology and Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 4605, USA
    J Mol Diagn 9:297-304. 2007
    ..The experimental variability was 18%. Overall, the data suggest that iLPA technology will be a relatively simple and inexpensive method for molecular measurements from tissue sections...
  23. pmc Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience
    Keith J Kowalczyk
    Department of Health and Human Services, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 1107, USA
    J Urol 182:2158-63. 2009
    ..We report on the outcomes of partial nephrectomy on kidneys previously treated with radio frequency ablation...
  24. pmc UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer
    Youfeng Yang
    Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1107, Bldg 10 CRC, Room 1 5942, Bethesda, MD 20892 1107
    Cancer Genet Cytogenet 196:45-55. 2010
    ..This tumor model is the embodiment of the Warburg effect. UOK 262 provides a unique in vitro and in vivo preclinical model for studying the bioenergetics of the Warburg effect in human cancer...
  25. pmc Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis
    Craig G Rogers
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    J Urol 180:2353-6; discussion 2356. 2008
    ..Tumors located adjacent to the renal hilum pose an additional challenge. We report a multi-institutional study of robotic partial nephrectomy for renal hilar tumors and describe our results...
  26. doi request reprint Assessment of critical renal ischemia with real-time infrared imaging
    Alexander M Gorbach
    Laboratory of Bioengineering and Physical Science, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, USA
    J Surg Res 149:310-8. 2008
    ..These temperature profiles then underwent spectral (frequency) analysis to assess their relationship to well-described oscillations of the microcirculation...
  27. ncbi request reprint Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy
    Jean Baptiste Lattouf
    Urologic Oncology Branch, National Cancer Institute, Room 1 5942, Building 10 CRC, 9000 Rockville Pike, Bethesda, MD 20892, USA
    Nat Clin Pract Urol 3:590-601. 2006
    ..Studies being conducted in prostate cancer will hopefully help to define this potential application better...
  28. ncbi request reprint A phase I feasibility study of an intraprostatic prostate-specific antigen-based vaccine in patients with prostate cancer with local failure after radiation therapy or clinical progression on androgen-deprivation therapy in the absence of local definitive
    Jean Baptiste Lattouf
    Urologic Oncology Branch, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Clin Genitourin Cancer 5:89-92. 2006
  29. ncbi request reprint Concomitant surgery with laparoscopic live donor nephrectomy
    Ernesto P Molmenti
    Johns Hopkins University School of Medicine, Department of Surgery, Baltimore, MD, USA
    Am J Transplant 3:219-23. 2003
    ..This practice is beneficial to both the donor and the recipient, and is likely to become more commonplace with changing practice patterns involving donor evaluation and management...